The aim of the present study was to examine the willingness of family members caring for patients with probable Alzheimer’s Disease (AD) to pay for drug treatment, using the contingent valuation technique and the theory of planned behavior. A sample of 220 family members (68.2% F, mean age = 62.3; 59.8% spouses and the rest children) were interviewed regarding their willingness to pay (WTP) for drug treatment, their attitudes, normative expectations of significant others and perceived behavioral control. The mean WTP for drug treatment was estimated at about 60–80% of the retail price of the drug at the time of the study. Participants were willing to pay a significantly higher price when provided with information regarding side effects. Including psychological determinants (especially regarding affordability and normative expectations of significant others) improved an economic model. The understanding of decision-making processes in the framework of dementia should be expanded to include economic and psychological determinants.
Ajzen, I.
(1991).The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179–211.
2.
Ajzen, I.
, & Driver, B.L. (1992). Contingent value measurement: On the nature and meaning of willingness to pay. Journal of Consumer Psychology, 1(4), 297–316.
3.
Chiu, L.
,Tang, K., Liu, Y., Shyu, W., & Chang, T. (1998).Willingness of families caring for victims of dementia to pay for nursing home care: Results of a pilot study in Taiwan. Journal of Management in Medicine, 12(6), 349–360.
4.
Cooper, B.
(1997). Epidemiology of the dementias of late life. In R. Jacoby & C. Oppenheimer (Eds.), Psychiatry in the elderly, 2nd edn.Oxford: Oxford University Press.
5.
Diaz Brinton, R.
, & Yamazaki, R.S. (1998). Advances and challenges in the prevention and treatment of Alzheimer’s disease. Pharmacological Research, 15(3), 386–398.
6.
Dieckmann, L.
, Zarit, A.S.H., Zarit, J.M., & Gatz, M. (1988).The Alzheimer’s disease knowledge test. Gerontologist, 28(3), 402–407.
7.
Diener, A.
, O’Brien, B., & Gafni, A. (1998). Health care contingent valuation studies: A review and classification of the literature. Health Economics, 7, 313–326.
8.
Donaldson, C.
, Shackley, P., & Abdalla, M. (1997). Using willingness to pay to value close substitutes: Carries screening for cystic fibrosis revisited. Health Economics,6, 145–159.
9.
Drebing, C.E.
(1999).Trends in the content and methodology of Alzheimer caregiving research. Alzheimer Disease and Related Disorders, 13 (Suppl. 1), S93–S100.
10.
Folstein, M.
, Folstein, S., & McHugh, P. (1975).‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
11.
Ham, R.J.
(1999). Evolving standards in patient and caregiver support. Alzheimer’s Disease and Associated Disorders, 13 (Suppl. 2), S27–S35.
12.
Hicks, M.H.
, & Lam, M.S. (1999). Decision-making within the social course of dementia: Accounts by Chinese-American caregivers. Culture, Medicine and Psychiatry, 23, 415–452.
13.
Johanesson, M.
, Jonsson, B., & Borgquist, L. (1991).Willingness to pay for anti-hypertensive therapy: Results of a Swedish pilot study. Journal of Health Economics, 10, 461–474.
14.
Jungermann, H.
, Schutz, H., & Thuring, M. (1988). Mental models on risk assessment: Informing people about drugs. Risk Analysis, 8(1), 147–155.
15.
Kartman, B.
, Andersson, F., & Johannesson, M. (1996).Willingness to pay for reductions in angina pectoris attacks. Medical Decision Making, 16, 248–253.
16.
Kartman, B.
, Stalhammar, N., & Johannesson, M. (1996).Valuation of health changes with the contingent valuation method: A test of scope and question order effects. Health Economics, 5, 531–541.
17.
Katz, S.
, Ford, A.B., & Moskowitz, R.W. (1963). A standardized index of biological and psychosocial function. Journal of the American Medical Association, 185, 414–419.
18.
Lee, S.J.
, Liljas, B., Neumann, P.J.,Weinstein, M.C., & Johannesson, M. (1998).The impact of risk information on patients’ willingness to pay for autologous blood donation. Medical Care, 36(8), 1162–1173.
19.
Lindholm, C.
, & Diderichsen, F. (1998). Contingent valuation as a method for measuring the effects of rehabilitation. International Journal of Rehabilitation Research, 21, 87–92.
20.
Luzar, E.J.
, & Cosse, K.J. (1998).Willingness to pay or intention to pay:The attitude–behavior relationship in contingent valuation. Journal of Socio-Economics, 27(3), 427–444.
21.
Mattsson, L.
, & Li, Ch. (1994). Sample nonresponse in a mail contingent valuation survey: An empirical test of the effect on value inference. Journal of Leisure Research, 26(2), 182–188.
22.
Neumann, P.J.
, & Johannesson, M. (1994).The willlingness to pay for in vitro fertilization: A pilot study using contingent valuation. Medical Care, 32(7), 686–699.
23.
Patterson, C.J.S.
, Gauthier, S., Bergman, H., Cohen, C.A., Feightner, J.W., Feldman, H., & Hogan, D.B. (1999).The recognition, assessment and management of dementing disorders: Conclusion from the Canadian Consensus Conference on Dementia. Canadian Medical Association Journal, 160 (Suppl. 12), S1–S15.
24.
Pauly, M.V.
(1996).Valuing health care benefits in money terms. In F.A. Sloan (Ed.), Valuing health care costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. New York: Cambridge University Press.
25.
Peskind, E.R.
(1998). Pharmacologic approaches to cognitive deficits in Alzheimer’s disease. Journal of Clinical Psychiatry, 59 (Suppl. 9), 22–27.
26.
Ryan, M.
, Ratcliffe, J., & Tucker, J. (1997). Using willingness to pay to value alternative models of antenatal care. Social Sciences and Medicine, 44(3), 371–380.
27.
Stalhammar, N.
(1996). An empirical note on willingness to pay and starting-point bias. Medical Decision Making, 16, 242–247.
28.
Stavem, K.
(1999).Willingness to pay: A feasible method for assessing treatment benefits in epilepsy?Seizure, 8(1), 14–19.
29.
Trabucchi, M.
(1999). An economic perspective on Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 12(1), 29–38.
30.
Werner, P.
, Heinik, J., Mendel, A. et al. (1999). Examining the reliability and validity of the Hebrew version of the Mini Mental State Examination. Aging:Experimental and Clinical Research, 11, 329–334.
31.
Whitehead, J.C.
(1994). Item nonresponse in contingent valuation: Should CV researchers impute values for missing independent variables?Journal of Leisure Research, 26(3), 296–303.
32.
Winblad, B.
, & Wimo, A. (1999). Assessing the societal impact of acetylcholinesterase inhibitor therapies. Alzheimer’s Disease and Associated Disorders, 13 (Suppl. 2), S9–S19.
33.
Zethraeus, N.
(1998).Willingness to pay for hormone replacement therapy. Health Economics, 7, 31–38.
